0000899243-20-027692.txt : 20201006 0000899243-20-027692.hdr.sgml : 20201006 20201006212601 ACCESSION NUMBER: 0000899243-20-027692 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201006 FILED AS OF DATE: 20201006 DATE AS OF CHANGE: 20201006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Salter Malcolm CENTRAL INDEX KEY: 0001825124 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39567 FILM NUMBER: 201227953 MAIL ADDRESS: STREET 1: C4 THERAPEUTICS, INC. STREET 2: 490 ARSENAL WAY, SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: C4 Therapeutics, Inc. CENTRAL INDEX KEY: 0001662579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475617627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (617) 231-0700 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-06 0 0001662579 C4 Therapeutics, Inc. CCCC 0001825124 Salter Malcolm C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 1 0 0 0 Common Stock 2020-10-06 4 C 0 11856 A 11856 D Common Stock 2020-10-06 4 C 0 2823 A 14679 D Common Stock 2020-10-06 4 P 0 1315 19.00 A 15994 D Series A Preferred Stock 2020-10-06 4 C 0 100000 0.00 D Common Stock 11856 0 D Series B Preferred Stock 2020-10-06 4 C 0 23809 0.00 D Common Stock 2823 0 D Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date. /s/ Jolie M. Siegel, Attorney-in-Fact 2020-10-06